Episode 40. Management of Newly Diagnosed AL Amyloidosis with Dr. Angela Dispenzieri Blood Cancer Talks

In this episode we discuss the management of newly diagnosed AL amyloidosis with Dr. Angela Dispenzieri from the Mayo Clinic. 
Here are the key articles discussed:
1.      Optimal use of tissue biopsy in AL amyloidosis: https://pubmed.ncbi.nlm.nih.gov/28271734/
 
2.     Mayo 2004 staging:  https://pubmed.ncbi.nlm.nih.gov/15365071/
 
3.     Mayo 2012 staging: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3675680/
 
4.     Renal staging: https://pubmed.ncbi.nlm.nih.gov/25115890/
 
5.     Hematologic and cardiac response criteria in AL amyloidosis: https://pubmed.ncbi.nlm.nih.gov/23091105/
 
6.     ANDROMEDA Trial: Dara-VCD vs VCD in newly diagnosed AL amyloidosis: https://pubmed.ncbi.nlm.nih.gov/34192431/
 
7.      How I Treat AL Amyloidosis: https://pubmed.ncbi.nlm.nih.gov/34517412/
 
8.     Venetoclax in AL amyloidosis (largest retrospective study till date): 
https://pubmed.ncbi.nlm.nih.gov/33431806/